You don't have permission to access "http://www.medpagetoday.com/neurology/alzheimersdisease/120668" on this server. Reference #18.2c153b17.1775512948.a208d49 https://errors.edgesuite.net/18.2c153b17.1775512948.a208d49
Millions of Americans are taking GLP-1 agonist medications like Ozempic, Wegovy, and Zepbound to lose weight, treat type 2 diabetes, and manage other chronic health conditions. And while these drugs are generally really effective, they can also bring on some not-so-great side effects, including a big drop in muscle mass for some people. Losing muscle
Four companies control about 80 percent of the U.S. beef market, and there is no reason to believe that any of them are satisfied with their share. Published: April 05, 2026, 8:00 am The USDA’s Food Safety and Inspection Service (FSIS) reported that Listeria monocytogenes was the most frequent cause of outbreaks it investigated during fiscal year
Céline Gounder, KFF Health News’ editor-at-large for public health, discussed a new weight loss pill approved by the FDA on CBS News’ CBS Mornings on April 2. Click here to watch Gounder on CBS Mornings. KFF Health News Southern correspondent Sam Whitehead discussed high Affordable Care Act premiums on WUGA’s The Georgia Health Report on
States are paying contractors such as Deloitte, Accenture, and Optum millions of dollars to help them comply with the One Big Beautiful Bill Act — a law that will strip safety-net health and food benefits from millions. State governments rely on such companies to design and operate computer systems that assess whether low-income people qualify
Carolina Cardona highlights all Central Florida has to offer in her stories on News 6 at Nine. She joined News 6 in June 2018 from the Telemundo station in Philadelphia.
You don't have permission to access "http://www.medpagetoday.com/neurology/alzheimersdisease/120668" on this server. Reference #18.2c153b17.1775512948.a208d49 https://errors.edgesuite.net/18.2c153b17.1775512948.a208d49
Millions of Americans are taking GLP-1 agonist medications like Ozempic, Wegovy, and Zepbound to lose weight, treat type 2 diabetes, and manage other chronic health conditions. And while these drugs are generally really effective, they can also bring on some not-so-great side effects, including a big drop in muscle mass for some people. Losing muscle
Four companies control about 80 percent of the U.S. beef market, and there is no reason to believe that any of them are satisfied with their share. Published: April 05, 2026, 8:00 am The USDA’s Food Safety and Inspection Service (FSIS) reported that Listeria monocytogenes was the most frequent cause of outbreaks it investigated during fiscal year
You don't have permission to access "http://www.medpagetoday.com/neurology/alzheimersdisease/120668" on this server. Reference #18.2c153b17.1775512948.a208d49 https://errors.edgesuite.net/18.2c153b17.1775512948.a208d49
Millions of Americans are taking GLP-1 agonist medications like Ozempic, Wegovy, and Zepbound to lose weight, treat type 2 diabetes, and manage other chronic health conditions. And while these drugs are generally really effective, they can also bring on some not-so-great side effects, including a big drop in muscle mass for some people. Losing muscle
Four companies control about 80 percent of the U.S. beef market, and there is no reason to believe that any of them are satisfied with their share. Published: April 05, 2026, 8:00 am The USDA’s Food Safety and Inspection Service (FSIS) reported that Listeria monocytogenes was the most frequent cause of outbreaks it investigated during fiscal year